Project Grant HT94252510337
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Trustees of the University of Pennsylvania received a $812,344 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on A Novel Inflammatory Mediator for Rheumatoid Arthritis from July 15, 2021 through July 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The Trustees of the University of Pennsylvania received a $568,256 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2021 to July 31, 2024 to examine the role of microenvironment mechanics in sarcoma immune evasion. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,178,136.00 to The Trustees of the University of Pennsylvania to conduct research on exploiting the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The research aims to transform healthcare for military service members and the broader public by advancing innovative approaches to disease...
The Trustees of the University of Pennsylvania will receive $568,750 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2025 to develop treatment of chondrosarcoma, a type of bone cancer, using YAP siRNA nanoparticles in a novel mouse model of chondrosarcoma. The Military Medical Research and Development program (CFDA 12.420) supports basic, applied,...
The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public...
The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
This $1,305,270 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the "Ovarian Cancer Academy: Advancing Ovarian Cancer Research through Mentorship, Networking, and Collaborations" initiative led by The Trustees of the University of Pennsylvania. The award aims to transform healthcare for military service members and the general public through innovative biomedical research in...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...